Heidi Rossmann

13PUBLICATIONS
24CO-AUTHORS
Cancer diagnosisMajor global burdens of diseasePredictive and prognostic markersMedical infection agents (incl. prions)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 14, 2026
The Pitfalls of Calcitonin as a Tumor Marker: Real-Life Data of Patients with Elevated Basal Calcitonin Levels but Without Evidence of Medullary Thyroid Carcinoma.

Ann-Kathrin Lederer, Constantin-Leonard Jacob Kessler, Nabila Bouzakri

|Dec 09, 2023
Hereditary Spherocytosis: Can Next-Generation Sequencing of the Five Most Frequently Affected Genes Replace Time-Consuming Functional Investigations?

Friederike Häuser, Heidi Rossmann, Anke Adenaeuer

|Sep 25, 2023
Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study.

Katharina Hoeter, Elmo Neuberger, Susanne Fischer

|Jul 03, 2023
A novel von Willebrand factor multimer ratio as marker of disease activity in thrombotic thrombocytopenic purpura.

Tanja Falter, Heidi Rossmann, Laure de Waele

|May 11, 2023
One fits all: a highly sensitive combined ddPCR/pyrosequencing system for the quantification of microchimerism after hematopoietic and solid organ transplantation.

Friederike Häuser, Jens Mittler, Misra Simge Hantal

|Oct 14, 2022
Novel GATA1 Variant Causing a Bleeding Phenotype Associated with Combined Platelet α-/δ-Storage Pool Deficiency and Mild Dyserythropoiesis Modified by a SLC4A1 Variant.

Kerstin Jurk, Anke Adenaeuer, Stefanie Sollfrank

Pageof 3

Frequent Collaborators

6 joint publications

Bernhard Lämmle

3 joint publications

Anke Adenaeuer

2 joint publications

Kerstin Jurk

2 joint publications

Stefano Barco